-
1
-
-
0029294531
-
Peroxisome proliferator activated receptors-transcriptional regulators of adipogenesis, lipid metabolism and more
-
Wahli, W., O. Braissant, and B. Desvergne. 1995. Peroxisome proliferator activated receptors-transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol. 2: 261-266.
-
(1995)
Chem Biol.
, vol.2
, pp. 261-266
-
-
Wahli, W.1
Braissant, O.2
Desvergne, B.3
-
2
-
-
0029994543
-
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
-
Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37: 907-925.
-
(1996)
J. Lipid Res.
, vol.37
, pp. 907-925
-
-
Schoonjans, K.1
Staels, B.2
Auwerx, J.3
-
3
-
-
0031898610
-
PPAR-gamma - Adipogenic regulator and thiazolidinedione receptor
-
Spiegelman, B. M. 1998. PPAR-gamma - adipogenic regulator and thiazolidinedione receptor. Diabetes. 47: 507-514.
-
(1998)
Diabetes
, vol.47
, pp. 507-514
-
-
Spiegelman, B.M.1
-
4
-
-
0025132245
-
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
-
Issemann, I., and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347: 645-650.
-
(1990)
Nature
, vol.347
, pp. 645-650
-
-
Issemann, I.1
Green, S.2
-
5
-
-
0028180070
-
mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
-
Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes & Dev. 8: 1224-1234.
-
(1994)
Genes & Dev.
, vol.8
, pp. 1224-1234
-
-
Tontonoz, P.1
Hu, E.2
Graves, R.A.3
Budavari, A.I.4
Spiegelman, B.M.5
-
6
-
-
0030047806
-
Differential expression of peroxisome proliferator-activated receptors (PPARs) - Tissue distribution of PPAR-α, -β, and -γ in the adult rat
-
Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs) - tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology. 137: 354-366.
-
(1996)
Endocrinology
, vol.137
, pp. 354-366
-
-
Braissant, O.1
Foufelle, F.2
Scotto, C.3
Dauca, M.4
Wahli, W.5
-
7
-
-
0032582349
-
PPAR-gamma-3 mRNA - A distinct PPAR-gamma mRNA subtype transcribed from an independent promoter
-
Fajas, L., J. C. Fruchart, and J. Auwerx. 1998. PPAR-gamma-3 mRNA - a distinct PPAR-gamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 438: 55-60.
-
(1998)
FEBS Lett.
, vol.438
, pp. 55-60
-
-
Fajas, L.1
Fruchart, J.C.2
Auwerx, J.3
-
8
-
-
0028802627
-
Differential activation of peroxisome proliferator-activated receptors by eicosanoids
-
Yu, K., W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. McMahon, M. Brown, and M. A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270: 23975-23983.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 23975-23983
-
-
Yu, K.1
Bayona, W.2
Kallen, C.B.3
Harding, H.P.4
Ravera, C.P.5
McMahon, G.6
Brown, M.7
Lazar, M.A.8
-
9
-
-
0028972025
-
15-Deoxy-delta(12,14)-prostaglandin J(2) is a ligand for the adipocyte determination factor PPAR-gamma
-
Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta(12,14)-prostaglandin J(2) is a ligand for the adipocyte determination factor PPAR-gamma. Cell. 83: 803-812.
-
(1995)
Cell
, vol.83
, pp. 803-812
-
-
Forman, B.M.1
Tontonoz, P.2
Chen, J.3
Brun, R.P.4
Spiegelman, B.M.5
Evans, R.M.6
-
10
-
-
0030952937
-
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
-
Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci USA. 94: 4312-4317.
-
(1997)
Proc. Natl. Acad. Sci USA
, vol.94
, pp. 4312-4317
-
-
Forman, B.M.1
Chen, J.2
Evans, R.M.3
-
11
-
-
0029661982
-
The PPAR-alpha-leukotriene B-4 pathway to inflammation control
-
Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. 1996. The PPAR-alpha-leukotriene B-4 pathway to inflammation control. Nature. 384: 39-43.
-
(1996)
Nature
, vol.384
, pp. 39-43
-
-
Devchand, P.R.1
Keller, H.2
Peters, J.M.3
Vazquez, M.4
Gonzalez, F.J.5
Wahli, W.6
-
12
-
-
0028972026
-
A prostaglandin J(2) metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
-
Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J(2) metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83: 813-819.
-
(1995)
Cell
, vol.83
, pp. 813-819
-
-
Kliewer, S.A.1
Lenhard, J.M.2
Willson, T.M.3
Patel, I.4
Morris, D.C.5
Lehmann, J.M.6
-
13
-
-
0027525576
-
The peroxisome proliferator-activated receptor:Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
-
Issemann, I., R. A. Prince, J. D. Tugwood, and S. Green. 1993. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11: 37-47.
-
(1993)
J. Mol. Endocrinol.
, vol.11
, pp. 37-47
-
-
Issemann, I.1
Prince, R.A.2
Tugwood, J.D.3
Green, S.4
-
14
-
-
0030764696
-
Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism
-
Frøyland, L., L. Madsen, H. Vaagenes, G. K. Totland, J. Auwerx, H. Kryvi, B. Staels, and R. K. Berge. 1997. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J. Lipid Res. 38: 1851-1858.
-
(1997)
J. Lipid Res.
, vol.38
, pp. 1851-1858
-
-
Frøyland, L.1
Madsen, L.2
Vaagenes, H.3
Totland, G.K.4
Auwerx, J.5
Kryvi, H.6
Staels, B.7
Berge, R.K.8
-
15
-
-
0031049745
-
The cytochrome P450 4 (CYP4) family
-
Simpson, A. 1997. The cytochrome P450 4 (CYP4) family. Gen. Pharmacol. 28: 351-359.
-
(1997)
Gen. Pharmacol.
, vol.28
, pp. 351-359
-
-
Simpson, A.1
-
16
-
-
0029791412
-
PPAR-alpha and PPAR-gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
-
Schoonjans, K., J. Peinadoonsurbe, A. M. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, and J. Auwerx. 1996. PPAR-alpha and PPAR-gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15: 5336-5348.
-
(1996)
EMBO J.
, vol.15
, pp. 5336-5348
-
-
Schoonjans, K.1
Peinadoonsurbe, J.2
Lefebvre, A.M.3
Heyman, R.A.4
Briggs, M.5
Deeb, S.6
Staels, B.7
Auwerx, J.8
-
17
-
-
0023850852
-
Preadipocyte differentiation in vitro: Identification of a highly active adipogenic agent
-
Hiragun, A., M. Sato, and H. Mitsui. 1988. Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J. Cell. Physiol. 134: 124-130.
-
(1988)
J. Cell. Physiol.
, vol.134
, pp. 124-130
-
-
Hiragun, A.1
Sato, M.2
Mitsui, H.3
-
18
-
-
0026517080
-
Enhancement of adipocyte differentiation by an insulin-sensitizing agent
-
Kletzien, R. F., S. D. Clarke, and R. G. Ulrich. 1992. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Pharmacol. 41: 393-398.
-
(1992)
Mol. Pharmacol.
, vol.41
, pp. 393-398
-
-
Kletzien, R.F.1
Clarke, S.D.2
Ulrich, R.G.3
-
19
-
-
0028641559
-
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
-
Tontonoz, P., E. D. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 79: 1147-1156.
-
(1994)
Cell
, vol.79
, pp. 1147-1156
-
-
Tontonoz, P.1
Hu, E.D.2
Spiegelman, B.M.3
-
20
-
-
0029981772
-
Differential activation of adipogenesis by multiple PPAR isoforms
-
Brun, R. P., P. Tontonoz, B. M. Forman, R. Ellis, J. Chen, R. M. Evans, and B. M. Spiegelman. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes & Dev. 10:974-984.
-
(1996)
Genes & Dev.
, vol.10
, pp. 974-984
-
-
Brun, R.P.1
Tontonoz, P.2
Forman, B.M.3
Ellis, R.4
Chen, J.5
Evans, R.M.6
Spiegelman, B.M.7
-
21
-
-
0028884048
-
Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling
-
Young, P. W., M. A. Cawthorne, P. J. Coyle, J. C. Holder, G. D. Holman, I. J. Kozka, D. M. Kirkham, C. A. Lister, and S. A. Smith. 1995. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes. 44: 1087-1092.
-
(1995)
Diabetes
, vol.44
, pp. 1087-1092
-
-
Young, P.W.1
Cawthorne, M.A.2
Coyle, P.J.3
Holder, J.C.4
Holman, G.D.5
Kozka, I.J.6
Kirkham, D.M.7
Lister, C.A.8
Smith, S.A.9
-
22
-
-
15444347751
-
Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker Fa/Fa rat
-
Hallakou, S., L. Doare, F. Foufelle, M. Kergoat, M. Guerre-Millo, M. F. Berthault, I. Dugail, J. Morin, J. Auwerx, and P. Ferre. 1997. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker Fa/Fa rat. Diabetes. 46: 1393-1399.
-
(1997)
Diabetes
, vol.46
, pp. 1393-1399
-
-
Hallakou, S.1
Doare, L.2
Foufelle, F.3
Kergoat, M.4
Guerre-Millo, M.5
Berthault, M.F.6
Dugail, I.7
Morin, J.8
Auwerx, J.9
Ferre, P.10
-
23
-
-
0020572164
-
Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice
-
Chang, A. Y., B. M. Wyse, and B. J. Gilchrist. 1983. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice. Diabetes. 32: 839-845.
-
(1983)
Diabetes
, vol.32
, pp. 839-845
-
-
Chang, A.Y.1
Wyse, B.M.2
Gilchrist, B.J.3
-
24
-
-
0027972524
-
Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance
-
Hofmann, C., K. Lorenz, S. S. Braithwaite, J. R. Colca, B. J. Palazuk, G. S. Hotamisligil, and B. M. Spiegelman. 1994. Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance. Endocrinology. 134: 264-270.
-
(1994)
Endocrinology
, vol.134
, pp. 264-270
-
-
Hofmann, C.1
Lorenz, K.2
Braithwaite, S.S.3
Colca, J.R.4
Palazuk, B.J.5
Hotamisligil, G.S.6
Spiegelman, B.M.7
-
25
-
-
0029078449
-
Regulated expression of the obese gene product (Leptin) in white adipose tissue and 3T3-L1 adipocytes
-
Macdougald, O. A., C. S. Hwang, H. Y. Fan, and M. D. Lane. 1995. Regulated expression of the obese gene product (Leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 92: 9034-9037.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 9034-9037
-
-
Macdougald, O.A.1
Hwang, C.S.2
Fan, H.Y.3
Lane, M.D.4
-
26
-
-
15844415080
-
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice
-
Zhang, B., M. P. Graziano, T. W. Doebber, M. D. Leibowitz, S. White-Carrington, D. M. Szalkowski, P. J. Hey, M. Wu, C. A. Cullinan, P. Bailey, B. Lollmann, R. Frederich, J. S. Flier, C. D. Strader, and R. G. Smith. 1996. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271: 9455-9459.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 9455-9459
-
-
Zhang, B.1
Graziano, M.P.2
Doebber, T.W.3
Leibowitz, M.D.4
White-Carrington, S.5
Szalkowski, D.M.6
Hey, P.J.7
Wu, M.8
Cullinan, C.A.9
Bailey, P.10
Lollmann, B.11
Frederich, R.12
Flier, J.S.13
Strader, C.D.14
Smith, R.G.15
-
27
-
-
0030040740
-
Regulation of ob gene mRNA levels in cultured adipocytes
-
Rentsch, J., and M. Chiesi. 1996. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379: 55-59.
-
(1996)
FEBS Lett.
, vol.379
, pp. 55-59
-
-
Rentsch, J.1
Chiesi, M.2
-
28
-
-
0028817459
-
Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme a oxidase - A potential mechanism for the hypolipidemic action of fibrates
-
Staels, B., N. Vudac, V. A. Kosykh, R. Saladin, J. C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme a oxidase - a potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 705-712
-
-
Staels, B.1
Vudac, N.2
Kosykh, V.A.3
Saladin, R.4
Fruchart, J.C.5
Dallongeville, J.6
Auwerx, J.7
-
29
-
-
0028998129
-
Mode of action of peroxisome proliferators as hypolipidemic drugs - Suppression of apolipoprotein C-III
-
Hertz, R., J. Bisharashieban, and J. Bartana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs - suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 13470-13475
-
-
Hertz, R.1
Bisharashieban, J.2
Bartana, J.3
-
30
-
-
0028172089
-
Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis
-
Ashby, J., A. Brady, C. R. Elcombe, B. M. Elliott, J. Ishmael, J. Odum, J. D. Tugwood, S. Kettle, and I. F. Purchase. 1994. Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13: S1-117.
-
(1994)
Hum. Exp. Toxicol.
, vol.13
-
-
Ashby, J.1
Brady, A.2
Elcombe, C.R.3
Elliott, B.M.4
Ishmael, J.5
Odum, J.6
Tugwood, J.D.7
Kettle, S.8
Purchase, I.F.9
-
31
-
-
0001844288
-
Antihyperglycaemic thiazolidinediones: Ciglitazone and its analogues
-
C. J. Bailey and P. R. Flatt, editors. Eldered Smith-Gordon, London
-
Colca, J. R., and D. R. Morton. 1990. Antihyperglycaemic thiazolidinediones: ciglitazone and its analogues. In New Antidiabetic Drugs. C. J. Bailey and P. R. Flatt, editors. Eldered Smith-Gordon, London. 255-261.
-
(1990)
New Antidiabetic Drugs
, pp. 255-261
-
-
Colca, J.R.1
Morton, D.R.2
-
32
-
-
0027988554
-
[[Omega-(heterocyclylamino)alkoxy]benzyl]-2, 4-thiazolidinediones as potent antihyperglycemic agents
-
Cantello, B. C. C., M. A. Cawthorne, G. P. Cottam, P. T. Duff, D. Haigh, R. M. Kindley, C. A. Lister, S. A. Smith, and P. L. Thurlby. 1994. [[Omega-(heterocyclylamino)alkoxy]benzyl]-2, 4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 37: 3977-3985.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3977-3985
-
-
Cantello, B.C.C.1
Cawthorne, M.A.2
Cottam, G.P.3
Duff, P.T.4
Haigh, D.5
Kindley, R.M.6
Lister, C.A.7
Smith, S.A.8
Thurlby, P.L.9
-
33
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR-gamma)
-
Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR-gamma). J. Biol. Chem. 270: 12953-12956.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
34
-
-
0031909945
-
Troglitazone - Review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus
-
Johnson, M. D., L. K. Campbell, and R. K. Campbell. 1998. Troglitazone - review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. Ann. Pharmacother. 32: 337-348.
-
(1998)
Ann. Pharmacother.
, vol.32
, pp. 337-348
-
-
Johnson, M.D.1
Campbell, L.K.2
Campbell, R.K.3
-
35
-
-
0001677801
-
Rosiglitazone (BRL49653) monotherapy has significant glucose lowering effect in type 2 diabetic patients
-
Patel, J., E. Miller, and R. Patwardhan. 1998. Rosiglitazone (BRL49653) monotherapy has significant glucose lowering effect in type 2 diabetic patients. Diabetes. 47: A17.
-
(1998)
Diabetes
, vol.47
-
-
Patel, J.1
Miller, E.2
Patwardhan, R.3
-
36
-
-
0032951971
-
A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643
-
Edvardsson, U., M. Alexandersson, F. Nilsson, H. Brockenhuus von Löwenhielm, A-C. Nyström, B. Ljung, and B. Dahllöf. 1999. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis. 20: 935-942.
-
(1999)
Electrophoresis
, vol.20
, pp. 935-942
-
-
Edvardsson, U.1
Alexandersson, M.2
Nilsson, F.3
Brockenhuus Von Löwenhielm, H.4
Nyström, A.-C.5
Ljung, B.6
Dahllöf, B.7
-
37
-
-
0029095434
-
Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): The state of the art and the controversy of vertical versus horizontal systems
-
Görg, A., G. Boguth, C. Obermaier, A. Posch, and W. Weiss. 1995. Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): the state of the art and the controversy of vertical versus horizontal systems. Electrophoresis. 16: 1079-1086.
-
(1995)
Electrophoresis
, vol.16
, pp. 1079-1086
-
-
Görg, A.1
Boguth, G.2
Obermaier, C.3
Posch, A.4
Weiss, W.5
-
38
-
-
0029927505
-
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels
-
Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
-
(1996)
Anal. Chem.
, vol.68
, pp. 850-858
-
-
Shevchenko, A.1
Wilm, M.2
Vorm, O.3
Mann, M.4
-
39
-
-
0024978195
-
The QUEST system for quantitative analysis of two-dimensional gels
-
Garrels, J. I. 1989. The QUEST system for quantitative analysis of two-dimensional gels. J. Biol. Chem. 264: 5269-5282.
-
(1989)
J. Biol. Chem.
, vol.264
, pp. 5269-5282
-
-
Garrels, J.I.1
-
40
-
-
0030000088
-
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents
-
Vidalpuig, A., M. Jimenezlinan, B. B. Lowell, A. Hamann, E. Hu, B. Spiegelman, J. S. Flier, and D. E. Moller. 1996. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97: 2553-2561.
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 2553-2561
-
-
Vidalpuig, A.1
Jimenezlinan, M.2
Lowell, B.B.3
Hamann, A.4
Hu, E.5
Spiegelman, B.6
Flier, J.S.7
Moller, D.E.8
-
41
-
-
0032491614
-
Peroxisome proliferator-activated receptor α-isoform defiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
-
Costet, P., C. Legendre, J. More, A. Edgar, P. Galtier, and T. Pineau. 1998. Peroxisome proliferator-activated receptor α-isoform defiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 273: 29577-29585.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 29577-29585
-
-
Costet, P.1
Legendre, C.2
More, J.3
Edgar, A.4
Galtier, P.5
Pineau, T.6
|